Vesalius Biocapital

A European life sciences venture capital investor


About us

Vesalius Biocapital is an European life sciences venture capital fund with more than € 220 mio assets under management in three funds.

We are investing in appealing companies in drug development, medical devices & diagnostics and eHealth / mHealth, predominantly in Europe. Our portfolio companies address unmet medical & market needs and operate on the basis of strong intellectual property protection.


Fund 3

Vesalius Biocapital III

Vintage 2017 - >€70 million assets under management (first closing). In investment mode

read more



Vesalius News

Vesalius Biocapital Launches New Fund in Collaboration with Portuguese National Promotional Bank (IFD)
read more
Fund 3 Announces First Close
read more